CVS Caremark (CVS) Tops Q1 EPS by 2c; Boosts FY12 adj.-EPS Outlook; Guides Q2
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $93.02 -0.67%
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q1 EPS of $0.65, $0.02 better than the analyst estimate of $0.63. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $30.31 billion.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Retail Pharmacy segment same stores sales increased 8.4%.
CVS Caremark sees FY2012 EPS of $3.23-$3.33, versus the consensus of $3.27.
CVS Caremark sees Q2 2012 EPS of $0.78-$0.80, versus the consensus of $0.74.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
